The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption

Metastasis accounts for most deaths from breast cancer, driving the need for new therapeutics that can impede disease progression. Rationally designed peptides that take advantage of cancer-specific differences in cellular physiology are an emerging technology that offer promise as a treatment for m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lee, M W, Bassiouni, R, Sparrow, N A, Iketani, A, Boohaker, R J, Moskowitz, C, Vishnubhotla, P, Khaled, A S, Oyer, J, Copik, A, Fernandez-Valle, C, Perez, J M, Khaled, A R
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2014
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4047892/
https://ncbi.nlm.nih.gov/pubmed/24853427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2014.225
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge